Does MC1R Genotype Convey Information About Melanoma Risk Beyond Risk Phenotypes?

被引:77
作者
Kanetsky, Peter A. [1 ,2 ]
Panossian, Saarene [1 ]
Elder, David E. [2 ,3 ]
Guerry, DuPont [2 ,4 ]
Ming, Michael E. [2 ,5 ]
Schuchter, Lynn [2 ,4 ]
Rebbeck, Timothy R. [1 ,2 ]
机构
[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[2] Univ Penn, Abramson Canc Ctr, Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA
关键词
melanoma; melanocortin-1; receptor; pigmentation phenotype; genetic variation; MELANOCORTIN-1 RECEPTOR GENE; CUTANEOUS MELANOMA; SKIN-CANCER; VARIANTS; POPULATION; POLYMORPHISMS; PREDICTION;
D O I
10.1002/cncr.24994
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: A study was carried out to describe associations of MC1R variants and melanoma in a US population and to investigate whether genetic risk is modified by pigmentation characteristics and sun exposure measures METHODS: Melanoma patients (n = 960) and controls (n = 396) self-reported phenotypic characteristics and sun exposure via structured questionnaire and underwent a skin examination Logistic regression was used to estimate associations of high- and low-risk MC1R variants and melanoma, overall and within phenotypic and sun exposure strata A meta-analysis of results from published studies was undertaken RESULTS: Carriage of 2 low-risk or any high-risk MC1R variants was associated with increased risk of melanoma (odds ratio [OR], 17, 95% confidence interval [CI], 10-2 8, and OR, 2 2, 95% Cl, 1 5-3 0, respectively) However, risk was stronger in or limited to individuals with protective phenotypes and limited sun exposure, such as those who tanned well after repeated sun exposure (OR, 2 4, 95% Cl, 1 6-3 6), had dark hair (OR, 2 4, 95% Cl, 1 5-3 6), or had dark eyes (OR, 3 2, 95% Cl, 18-5 9) We noted this same pattern of increased melanoma risk among persons who did not freckle, tanned after exposure to first strong summer sun, reported little or average recreational or occupational sun exposure, or reported no sun burning events Meta-analysis of published literature supported these findings CONCLUSIONS: These data indicate that MC1R genotypes provide information about melanoma risk in those individuals who would not be identified as high risk based on their phenotypes or exposures alone Cancer 2010;116:2416-28. (C) 2010 American Cancer Society
引用
收藏
页码:2416 / 2428
页数:13
相关论文
共 25 条
  • [1] Beaumont Kimberley A, 2008, Hum Mutat, V29, pE88, DOI 10.1002/humu.20788
  • [2] The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma:: An international population-based study
    Berwick, Marianne
    Orlow, Irene
    Hummer, Amanda J.
    Armstrong, Bruce K.
    Kricker, Anne
    Marrett, Loraine D.
    Millikan, Robert C.
    Gruber, Stephen B.
    Anton-Culver, Hoda
    Zanetti, Roberto
    Gallagher, Richard P.
    Dwyer, Terence
    Rebbeck, Timothy R.
    Kanetsky, Peter A.
    Busam, Klaus
    From, Lynn
    Mujumdar, Urvi
    Wilcox, Homer
    Begg, Colin B.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (08) : 1520 - 1525
  • [3] RISK OF CUTANEOUS MELANOMA-ASSOCIATED WITH PIGMENTATION CHARACTERISTICS AND FRECKLING - SYSTEMATIC OVERVIEW OF 10 CASE-CONTROL STUDIES
    BLISS, JM
    FORD, D
    SWERDLOW, AJ
    ARMSTRONG, BK
    CRISTOFOLINI, M
    ELWOOD, JM
    GREEN, A
    HOLLY, EA
    MACK, T
    MACKIE, RM
    OSTERLIND, A
    WALTER, SD
    PETO, J
    EASTON, DF
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (04) : 367 - 376
  • [4] A pooled analysis of Melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes
    Chang, Yu-mei
    Newton-Bishop, Julia A.
    Bishop, D. Timothy
    Armstrong, Bruce K.
    Bataille, Veronique
    Bergman, Wilma
    Berwick, Marianne
    Bracci, Paige M.
    Elwood, J. Mark
    Ernstoff, Marc S.
    Green, Adele C.
    Gruis, Nelleke A.
    Holly, Elizabeth A.
    Ingvar, Christian
    Kanetsky, Peter A.
    Karagas, Margaret R.
    Le Marchand, Loic
    Mackie, Rona M.
    Olsson, Hakan
    Osterlind, Anne
    Rebbeck, Timothy R.
    Reich, Kristian
    Sasieni, Peter
    Siskind, Victor
    Swerdlow, Anthony J.
    Titus-Ernstoff, Linda
    Zens, Michael S.
    Ziegler, Andreas
    Barrett, Jennifer H.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (02) : 420 - 428
  • [5] Risk factors and individual probabilities of melanoma for whites
    Cho, E
    Rosner, BA
    Feskanich, D
    Colditz, GA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2669 - 2675
  • [6] Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?
    Dwyer, T
    Stankovich, JM
    Blizzard, L
    FitzGerald, LM
    Dickinson, JL
    Reilly, A
    Williamson, J
    Ashbolt, R
    Berwick, M
    Sale, MM
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (09) : 826 - 833
  • [7] Fargnoli MC, 2006, MELANOMA RES, V16, P175, DOI 10.1097/01.cmr.0000198454.11580.b5
  • [8] Identifying individuals at high risk of melanoma: A practical predictor of absolute risk
    Fears, Thomas R.
    Guerry, DuPont
    Pfeiffer, Ruth M.
    Sagebiel, Richard W.
    Elder, David E.
    Halpern, Allan
    Holly, Elizabeth A.
    Hartge, Patricia
    Tucker, Margaret A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (22) : 3590 - 3596
  • [9] Comprehensive evaluation of allele frequency differences of MC1R variants across populations
    Gerstenblith, Meg R.
    Goldstein, Alisa M.
    Fargnoli, Maria Concetta
    Peris, Ketty
    Landi, Maria Teresa
    [J]. HUMAN MUTATION, 2007, 28 (05) : 495 - 505
  • [10] Identification of high-risk patients among those diagnosed with thin cutaneous melanomas
    Gimotty, Phyllis A.
    Elder, David E.
    Fraker, Douglas L.
    Botbyl, Jeffrey
    Sellers, Kimberly
    Elenitsas, Rosalie
    Ming, Michael E.
    Schuchter, Lynn
    Spitz, Francis R.
    Czerniecki, Brian J.
    Guerry, DuPont
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (09) : 1129 - 1134